Thrombolytic therapy for late thrombosis of a bioprosthetic mitral valve: atypical diagnostic echocardiographic features and a review of the literature

J Heart Valve Dis. 2008 Nov;17(6):670-3.

Abstract

Bioprosthetic valves are generally considered to carry a low risk of valve thrombosis, obviating the need for long-term anticoagulation in most patients. Few reports exist of the diagnostic characteristics and management of bioprosthetic valve thrombosis. Herein is presented a case of critical bioprosthetic mitral valve thrombosis in which successful clinical and hemodynamic resolution was achieved with intravenous thrombolysis. A current review of the bioprosthetic valve thrombosis literature is also presented.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Bioprosthesis / adverse effects*
  • Dyspnea / etiology
  • Echocardiography
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Heart Valve Prosthesis / adverse effects*
  • Heparin / therapeutic use
  • Humans
  • Mitral Valve / diagnostic imaging*
  • Mitral Valve / surgery
  • Streptokinase / therapeutic use
  • Thrombolytic Therapy*
  • Thrombosis / diagnosis*
  • Thrombosis / drug therapy*
  • Thrombosis / etiology

Substances

  • Fibrinolytic Agents
  • Heparin
  • Streptokinase